Meeting Coverage


International Kidney Cancer Symposium

Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancer

Thirteen-month survival gain falls short of statistical significance in observational study

IKCS over a photo of the Hyatt Regency in Austin, TX.

Latest IKCS Meeting Coverage

Immune Stimulator May Enhance Targeted Therapy's Activity in Metastatic RCC

Numerical advantage in median survival, response rate, durability with dendritic-cell agent

November 9, 2022
Immunotherapy Doublet Shows Promise for Nonsurgical Control of Small Kidney Cancers

Nivolumab/ipilimumab achieves 1-year PFS of 100% in unresectable T1N0M0 tumors

November 7, 2022
Probiotic May Rev Up Response to Immunotherapy in Advanced Kidney Cancer

Dramatic slowing of disease progression, prolonged responses with microbiome modulator

November 6, 2022
Metastatic Renal Cell Carcinoma: Watch for Brain Mets

Present in roughly 5% of patients, survival worse in patients with larger or more lesions

November 18, 2019
Kidney Cancer Patients Take to Twitter for Support, Info

Social media platform may be useful for trial recruitment, researchers say

November 5, 2017